Cisplatin efficacy. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy3

Cell Line, Tumor Tumor Cells, Cultured Kidney

Organisms2

Mice, Nude Mice, Inbred BALB C

Diseases32

Lung Neoplasms Ovarian Neoplasms Vomiting Head and Neck Neoplasms Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Leukopenia Nausea Adenocarcinoma Testicular Neoplasms Neoplasms Carcinoma, Small Cell Stomach Neoplasms Neutropenia Neoplasm Recurrence, Local Neoplasms, Germ Cell and Embryonal Germinoma Esophageal Neoplasms Mesothelioma Thrombocytopenia Pleural Neoplasms Carcinoma Urologic Neoplasms Disease Models, Animal Hematologic Diseases Uterine Cervical Neoplasms Neoplasm Metastasis Osteosarcoma Disease Progression Carcinoma, Transitional Cell Nasopharyngeal Neoplasms Peritoneal Neoplasms

Chemicals and Drugs43

Cisplatin Antineoplastic Agents Platinum Etoposide Deoxycytidine Fluorouracil Paclitaxel Vinblastine DNA Adducts Carboplatin Doxorubicin Ifosfamide Taxoids Camptothecin Mitomycin Antineoplastic Agents, Phytogenic Drug Combinations Oxonic Acid Tegafur Vindesine Bleomycin Antiemetics Ondansetron Antimetabolites, Antineoplastic Epirubicin Cyclophosphamide Methotrexate Radiation-Sensitizing Agents Guanine Amifostine Platinum Compounds Tumor Suppressor Protein p53 Antineoplastic Agents, Alkylating Granisetron Vincristine Metoclopramide Thiosulfates Carmustine Leucovorin Cross-Linking Reagents Glutathione Antibodies, Monoclonal, Humanized Mitomycins

Analytical, Diagnostic and Therapeutic Techniques and Equipment36

Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Drug Administration Schedule Combined Modality Therapy Survival Analysis Infusions, Intravenous Drug Screening Assays, Antitumor Disease-Free Survival Survival Rate Double-Blind Method Neoplasm Staging Drug Therapy, Combination Drug Evaluation Xenograft Model Antitumor Assays Follow-Up Studies Chemotherapy, Adjuvant Administration, Oral Prospective Studies Maximum Tolerated Dose Feasibility Studies Remission Induction Clinical Trials as Topic Disease Models, Animal Neoadjuvant Therapy Inhibitory Concentration 50 Randomized Controlled Trials as Topic Retrospective Studies Salvage Therapy Induction Chemotherapy Infusions, Intra-Arterial Dose Fractionation Pilot Projects Prognosis Kaplan-Meier Estimate Radiotherapy Dosage Injections, Intravenous

Phenomena and Processes15

Drug Resistance, Neoplasm Dose-Response Relationship, Drug DNA Adducts Drug Synergism Apoptosis Time Factors Cell Survival Drug Resistance DNA Damage DNA Repair Maximum Tolerated Dose Cell Proliferation Inhibitory Concentration 50 Gene Expression Regulation, Neoplastic Drug Interactions

Information Science1

Health Care13

Treatment Outcome Survival Analysis Disease-Free Survival Survival Rate Double-Blind Method Follow-Up Studies Prospective Studies Feasibility Studies Clinical Trials as Topic Randomized Controlled Trials as Topic Retrospective Studies Pilot Projects Kaplan-Meier Estimate

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Health Care

Cisplatin Antineoplastic Agents Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Platinum Drug Administration Schedule Drug Resistance, Neoplasm Lung Neoplasms Combined Modality Therapy Etoposide Deoxycytidine Ovarian Neoplasms Fluorouracil Cell Line, Tumor Paclitaxel Vinblastine Dose-Response Relationship, Drug DNA Adducts Vomiting Survival Analysis Head and Neck Neoplasms Carboplatin Drug Synergism Infusions, Intravenous Drug Screening Assays, Antitumor Doxorubicin Ifosfamide Carcinoma, Squamous Cell Taxoids Carcinoma, Non-Small-Cell Lung Apoptosis Disease-Free Survival Leukopenia Survival Rate Nausea Tumor Cells, Cultured Camptothecin Time Factors Cell Survival Double-Blind Method Neoplasm Staging Mitomycin Adenocarcinoma Antineoplastic Agents, Phytogenic Testicular Neoplasms Drug Therapy, Combination Drug Combinations Oxonic Acid Neoplasms Drug Resistance DNA Damage Carcinoma, Small Cell Tegafur Vindesine Bleomycin Mice, Nude Drug Evaluation Stomach Neoplasms Neutropenia Xenograft Model Antitumor Assays Antiemetics Neoplasm Recurrence, Local Neoplasms, Germ Cell and Embryonal Follow-Up Studies Chemotherapy, Adjuvant DNA Repair Administration, Oral Prospective Studies Maximum Tolerated Dose Ondansetron Antimetabolites, Antineoplastic Germinoma Epirubicin Esophageal Neoplasms Cyclophosphamide Mesothelioma Thrombocytopenia Feasibility Studies Methotrexate Remission Induction Clinical Trials as Topic Pleural Neoplasms Carcinoma Urologic Neoplasms Radiation-Sensitizing Agents Guanine Disease Models, Animal Amifostine Neoadjuvant Therapy Cell Proliferation Platinum Compounds Inhibitory Concentration 50 Randomized Controlled Trials as Topic Tumor Suppressor Protein p53 Antineoplastic Agents, Alkylating Retrospective Studies Kidney Hematologic Diseases Granisetron Vincristine

No FAQ available that match "cisplatin efficacy"